Gelomics announces appointment of Distinguished Professor Dietmar W. Hutmacher, PhD, MBA and Professor Travis J. Klein, PhD to its Scientific Advisory Board

Gelomics, a leading Australian biotech firm at the forefront of drug development innovation, is delighted to further strengthen its Scientific Advisory Board with the addition of Distinguished Professor Dietmar W. Hutmacher, PhD, MBA, and Professor Travis J. Klein, PhD. Following the recent appointment of Professor Dame Molly Stevens, FREng FRS, these new appointments reinforce our […]
LunaGel™ Ultrapure GelMA ECM Is Now Available

We’re thrilled to unveil our latest innovation: LunaGel™ Ultrapure GelMA Photocrosslinkable Extracellular Matrix (ECM), now available in both High Stiffness and Low Stiffness options. Developed in collaboration with Rousselot Biomedical, this breakthrough leverages the advanced X-Pure® GelMA technology, setting a new standard for 3D cell culture by offering unparalleled control over matrix porosity and stiffness. […]